Ibandronate Sodium
CAS 138844-81-2 5 FDA-DMF suppliersSmall Molecule
Overview
Ibandronate Sodium is a bisphosphonate class drug used to prevent and treat osteoporosis in postmenopausal women. It works by inhibiting osteoclast-mediated bone resorption, thus increasing bone mineral density.
API suppliers (6)
Suppliers of Ibandronate Sodium backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- Apotex Inc.Canada1 active DMF
- Apotex Inc.Canada1 active DMF
- ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
- ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
- ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
- Taro Pharmaceutical Industries Ltd.Israel
Therapeutic areas
OsteoporosisBone Disorders
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.